Sri Lanka

The primary regulatory authority for health products in Sri Lanka is the National Medicines Regulatory Authority (NMRA), established under the National Medicines Regulatory Authority Act No. 5 of 2015. The NMRA is responsible for the registration, licensing, and post-market surveillance of pharmaceuticals, medical devices, diagnostics, and related health products. All health products must be registered with the NMRA prior to importation, distribution, or sale in Sri Lanka. The registration process involves a scientific evaluation of safety, efficacy, and quality, and products are assigned to evaluation tracks based on their regulatory status in reference jurisdictions such as the US FDA, EMA, TGA, Health Canada, or other ICH-aligned authorities. Expedited review pathways may be available for products already approved by stringent regulatory authorities (SRAs).

Applications to the NMRA must be submitted in Common Technical Document (CTD) or ASEAN Common Technical Dossier (ACTD) format, depending on the product category. A locally registered agent or authorized representative based in Sri Lanka is mandatory for all foreign manufacturers seeking product registration. Applicants must provide certificates of pharmaceutical product (CPP) from the country of origin, Good Manufacturing Practice (GMP) compliance evidence, and locally relevant labeling. The NMRA has been undertaking ongoing reforms to modernize its regulatory framework, including digitization of submission processes, harmonization with WHO prequalification standards, and development of specific guidance for medical devices and in-vitro diagnostics, sectors that were historically less formally regulated than pharmaceuticals. Fee structures and classification frameworks for medical devices and digital health products are continuing to evolve.

Public sector procurement of health products in Sri Lanka is centrally coordinated through the Ministry of Health (MOH), primarily via the State Pharmaceuticals Corporation (SPC) and the State Pharmaceuticals Manufacturing Corporation (SPMC). The SPC is the principal procurement and distribution agency for pharmaceuticals, medical devices, and diagnostics destined for the public health system, including government hospitals and primary care facilities. Tenders are issued through the SPC and are subject to national procurement guidelines overseen by the National Procurement Commission. Products must be NMRA-registered to be eligible for public tender participation. The Medical Supplies Division (MSD) of the MOH manages logistics and warehousing for the public sector supply chain. Sri Lanka operates a largely centralized procurement model, with limited devolution to provincial health authorities for certain consumables and ancillary items.

The private sector represents a significant and growing channel for health product access in Sri Lanka, served by a network of private importers, distributors, and retail pharmacy chains operating independently of the SPC. Multinational companies typically engage local distributors or establish in-country representative offices to serve both public and private markets. Donor-funded procurement plays a supplementary role, with agencies such as UNICEF, the Global Fund (for HIV, tuberculosis, and malaria programs), and the World Health Organization (WHO) supporting targeted health commodity supply, particularly for communicable disease control and maternal and child health programs. USAID and Gavi have historically contributed to immunization and health system strengthening efforts. Sri Lanka maintains a policy preference for locally manufactured products in certain procurement categories, and the government has periodically introduced initiatives to support domestic pharmaceutical and medical device manufacturing as part of broader industrial policy objectives.